Charlene Thomas

Also affiliated with Presbyterian Hospital, Anna Needs Neuroblastoma Answers, Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 31 papers. Top paper: “Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591”.

Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591

Journal of Clinical Oncology(2023)10.1200/jco.23.00573

N/A

2.6DataRank · unranked

69 citations

Charlene Thomas, Oliver Sartor, Michael Sun, Judith Stangl‐Kremser, Mahelia Bissassar +10 more

Imaging expression of prostate‐specific membrane antigen and response to PSMA‐targeted β‐emitting radionuclide therapies in metastatic castration‐resistant prostate cancer

The Prostate(2021)10.1002/pros.24104

N/A

1.5DataRank · unranked

27 citations

Muhammad Junaid Niaz, Myrto Skafida, Seyed Ali Mosallaie, Charlene Thomas, Paul J. Christos +6 more

Dose-escalation results of a phase I study of 225Ac-J591 for progressive metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.114

N/A

0DataRank · unranked

24 citations

Joseph R. Osborne, Muhammad Junaid Niaz, Shankar Vallabhajosula, Panagiotis J. Vlachostergios, Charlene Thomas +9 more

Phase I dose-escalation study of PSMA-targeted alpha emitter 225Ac-J591 in men with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5560

N/A

0DataRank · unranked

10 citations

Joseph R. Osborne, Escarleth Fernandez, Charlene Thomas, Muhammad Junaid Niaz, Amy Ciriaco +10 more

Patient-reported outcomes (PRO) from a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.45

N/A

0DataRank · unranked

2 citations

Sukanya Goswami, Muhammad Junaid Niaz, Charlene Thomas, Paul J. Christos, Joseph R. Osborne +10 more

Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.05.011

N/A

0DataRank · unranked

89 citations

Ravi Sharaf, Rachel Saganty, Muhammad Danyal Ahsan, Julia Feit, Andrea Khoury +13 more

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer

Frontiers in Oncology(2021)10.3389/fonc.2021.630589

N/A

0DataRank · unranked

43 citations

Muhammad Junaid Niaz, Michael Sun, Seyed Ali Mosallaie, Charlene Thomas, Paul J. Christos +6 more

Association between low fetal fraction and hypertensive disorders of pregnancy in in vitro fertilization–conceived pregnancies

American Journal of Obstetrics & Gynecology MFM(2021)10.1016/j.ajogmf.2021.100463

N/A

0DataRank · unranked

5 citations

Pietro Bortoletto, Kelly McCarter, Kimberly N. Forlenza, Annie Yau, Charlene Thomas +3 more

Phase I study of 225Ac-J591 for men with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5015

N/A

0DataRank · unranked

30 citations

Michael Sun, Oliver Sartor, Charlene Thomas, Sharon Singh, Mahelia Bissassar +11 more

Long-term adverse events (AE) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving prostate-specific membrane antigen (PSMA)-based targeted radionuclide therapy (TRT).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5055

N/A

0DataRank · unranked

0 citations

Charlene Thomas, Benedict Ho, Muhammad Junaid Niaz, Ana M. Molina, Cora N. Sternberg +4 more

Age of first cancer diagnosis and survival in Bloom syndrome

Genetics in Medicine(2022)10.1016/j.gim.2022.03.008

N/A

0DataRank · unranked

27 citations

Maeve Flanagan, Charlene Thomas, Vivian Y. Chang, Michael F. Walsh, Christopher Cunniff +1 more

Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100941

N/A

0DataRank · unranked

9 citations

Isabel Wolfe, Muhammad Danyal Ahsan, Hannah Krinsky, Andreas Ian Lackner, Joe Pelt +12 more

What happens in the long term: Uptake of cancer surveillance and prevention strategies among at‐risk relatives with pathogenic variants detected via cascade testing

Cancer(2022)10.1002/cncr.34482

N/A

0DataRank · unranked

13 citations

Muhammad Danyal Ahsan, Nora Badiner, Jenny Lin, Priyanka Narayan, Roni Nitecki +15 more

Asthma 17q21 polymorphism associates with decreased risk of COVID‐19 in children

Pediatric Pulmonology(2022)10.1002/ppul.26091

N/A

0DataRank · unranked

6 citations

Rika Gomi, Madeline Young, Geancarlo Jordan, Madeline Liongson, Andrea Heras +10 more

Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial

Translational Oncology(2022)10.1016/j.tranon.2022.101593

N/A

0DataRank · unranked

6 citations

Kritika Subramanian, Sandra Huicochea Castellanos, Charlene Thomas, Arindam Roy Choudhury, Brett Muench +4 more

Phase I/II study of 225Ac-J591 plus 177Lu-PSMA-I&T for progressive metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps5100

N/A

0DataRank · unranked

5 citations

Joseph R. Osborne, Peter Gregos, Charlene Thomas, Mahelia Bissassar, Sharon Singh +14 more

Quantitative assessment of PSMA imaging before and after 177Lu-PSMA-617 treatment in a Ph I/II trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.037

N/A

0DataRank · unranked

2 citations

Charlene Thomas, Michael Sun, Oliver Sartor, Sharon Singh, Mahelia Bissassar +15 more

Assessment of patient-reported outcomes (PROs) and longer-term adverse events (AEs) in phase I study of 225Ac-J591-PSMA for metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.077

N/A

0DataRank · unranked

2 citations

Charlene Thomas, Benedict Ho, Juana Martinez Zuloaga, Brian D. Gonzalez, Michael Sun +15 more

Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis

PEC Innovation(2023)10.1016/j.pecinn.2023.100138

N/A

0DataRank · unranked

37 citations

Sarah R. Levi, Emily Webster, Hannah Bergeron, Jenny Lin, Priyanka Narayan +12 more

Extracranial Carotid Plaque Calcification and Cerebrovascular Ischemia: A Systematic Review and Meta-Analysis

Stroke(2023)10.1161/strokeaha.123.042807

N/A

0DataRank · unranked

26 citations

Atin Saha, Diana Delgado, Arindam RoyChoudhury, Charlene Thomas, Matthew Lin +4 more

Web-based tool for cancer family history collection: A prospective randomized controlled trial

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.04.001

N/A

0DataRank · unranked

21 citations

Muhammad Danyal Ahsan, Emily Webster, Sarah R. Levi, Jesse Brewer, Jenny Lin +11 more

Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population

Gynecologic Oncology Reports(2023)10.1016/j.gore.2023.101232

N/A

0DataRank · unranked

4 citations

Shanice Beaumont, Zhen Zhou, Jesse Brewer, Charlene Thomas, Eloise Chapman‐Davis +5 more

Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.07.017

N/A

0DataRank · unranked

7 citations

Muhammad Danyal Ahsan, Emily Webster, Luiza Perez, Sarah R. Levi, Benedict Harvey +13 more

Phase I dose-escalation results of prostate-specific membrane antigen-targeted radionuclide therapy (PSMA-TRT) with alpha-radiolabeled antibody 225Ac-J591 and beta-radioligand 177Lu-PSMA I&T.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5018

N/A

0DataRank · unranked

10 citations

Michael Philip Sun, Jones T. Nauseef, Charlene Thomas, Sandra Huicochea Castellanos, Joseph Earl Thomas +12 more

Relationship between adipokines and androgens in children and young adults with congenital adrenal hyperplasia

Frontiers in Endocrinology(2024)10.3389/fendo.2024.1433378

N/A

0DataRank · unranked

4 citations

Oksana Lekarev, Charlene Thomas, Yuan‐Shan Zhu, Kaela Cohan, Karen Lin‐Su +1 more

Final results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.5074

N/A

0DataRank · unranked

5 citations

Charlene Thomas, Jones T. Nauseef, Oliver Sartor, Michael Philip Sun, Sandra Huicochea Castellanos +14 more

A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative

The Lancet Neurology(2025)10.1016/s1474-4422(25)00154-1

N/A

0DataRank · unranked

155 citations

Kristen Dams-O'Connor, Michael L. Alosco, Hibah O. Awwad, Jeffery J. Bazarian, Peter Bragge +95 more

Altered Gut Microbiota in Pediatric Quiescent Crohn’s Disease Patients with Iron Deficiency Anemia

Inflammatory Bowel Diseases(2025)10.1093/ibd/izaf295

N/A

0DataRank · unranked

1 citations

Jérémy Goc, Alexander Grier, Charlene Thomas, JRI Live Cell Bank, David Artis +21 more

Phase I trial of docetaxel plus lutetium-177-labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer

Urologic Oncology Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.05.028

N/A

0DataRank · unranked

49 citations

Muhammad Junaid Niaz, Young E. Whang, Arif Sheikh, Charlene Thomas, Paul J. Christos +8 more

PSMA-targeted actinium-225 therapy in metastatic castration-resistant prostate cancer (mCRPC): Baseline and follow-up PSMA PET parameters associated with outcomes.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5070

N/A

0DataRank · unranked

1 citations

Charlene Thomas, Gabriel Raab, Aaron N. Holmes, Tobechukwu Okobi, Andres Ricaurte‐Fajardo +11 more

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.11.017

N/A

0DataRank · unranked

40 citations

Eloise Chapman‐Davis, Shannon Glynn, Jenny Lin, Annie E. Ellis, Shannon Tomita +8 more